Last Updated: October 3, 2025
Analyzing Management
Leadership at public companies plays a crucial role for hedge funds and asset managers during both initial due diligence and continuous risk assessment. ManagementTrack offers a consistent framework that eliminates distractions, highlighting distinct strengths and weaknesses, signaling potential red and green flags, and directly connecting CEO actions with financial performance.
CEO Duato’s litigation and execution woes may undermine his pharma background.
Analysis of Johnson & Johnson CEO Joaquin Duato
While his pharmaceutical background is an asset for offsetting patent loss, challenges with litigation and recent execution missteps may limit his effectiveness in resolving the company’s most pressing financial and reputational risks.
Management evaluated Joaquin Duato’s track record and skillset against the following key factors for JNJ:
- Accelerating TREMFYA and RYBREVANT sales to offset Stelara loss.
- Resolving talc litigation to remove financial and reputational risk.
- Executing the TAR-200 launch to validate $5B+ peak sales forecast.
- Offsetting the Stelara LOE to prove the new diversified model.
Joaquin Duato’s Track Record & Key Open Questions to Research
ManagementTrack provides track record analysis, career playbooks, strengths, and weaknesses for every CEO. It allows investors to dig deeper to uncover hard to find data to answer the most pressing questions.
Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ for more information.
Question #1
As Duato builds the MedTech pillar through large M&A, does his operational playbook favor strategic growth at the expense of the cost management and integration discipline required to deliver profitable returns on those acquisitions?
Question #2
When managing the talc crisis, does Duato prioritize aggressive legal maneuvering over the pragmatic resolution needed to restore investor confidence and remove the overhang from the business?
Question #3
Given the failure of the COVID-19 vaccine launch, does Duato possess the hands-on commercial execution skill to ensure a successful TAR-200 launch, or does his past pharma success not translate to a more complex corporate environment?
Why Do Investors Use ManagementTrack?
What is ManagementTrack’s assessment of Joaquin Duato at JNJ?
Through its proprietary career analysis and interviews with former colleagues, ManagementTrack establishes an executive’s track record, key strengths, and weaknesses. This profile is then benchmarked against JNJ’s most critical challenges: accelerating TREMFYA and RYBREVANT sales to offset the Stelara patent cliff, resolving the talc litigation to remove financial and reputational risk, executing a successful TAR-200 launch to justify its $5B+ peak sales forecast, and ultimately proving the new diversified model by navigating the Stelara loss of exclusivity.
What other methods does ManagementTrack use to connect executive leadership to future company performance?
ManagementTrack utilizes proprietary models that flag executive evasion during earnings call Q&A and assess whether that behavior is abnormal. Additionally, it analyzes the complete universe of insider transactions to identify outlier trades that are predictive of future stock movement. When combined with the ManagementTrack Rating, a predictive 1-10 score for every executive, these tools provide investors with a decisive, forward-looking perspective on how management ability will shape company performance.
What is the scope of ManagementTrack’s coverage?
ManagementTrack provides continuous, real-time analysis on the c-suite leadership of every public company.
How to Learn More
Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ to see our deep dive analysis on any executive.
Author
Author Colby Howard is the co-founder and President of Paragon Intel. Paragon Intel’s ManagementTrack is the premier executive analysis platform for hedge funds, asset managers, corporations, boards, and recruiters. Our proprietary data, built over a decade of analysis, allows us to analyze each public company executive to understand their fit and ability to execute at their company. We leverage our proprietary data – key quantitative research on an executive’s career plus interviews with their former colleagues – with public documents, including SEC filings (10-K, 10-Q), investor presentations, press releases, and earnings call transcripts. to build a holistic, evidence-based view of an executive’s capabilities and playbook.
Sources
Verified Career History by ManagementTrack for Joaquin Duato
Analysis of Capital Allocation, Performance, and Fundamentals across career by ManagementTrack
Johnson & Johnson 10Q
Johnson & Johnson 10K
Johnson & Johnson Earnings Calls
Johnson & Johnson Press Releases
Relevant Links
- For more information on ManagementTrack’s Data visit: https://paragonintel.com/management-track-data/
- For more information on ManagementTrack’s Interview & Analysis visit: https://paragonintel.com/management-track-reports/
- For more information on ManagementTrack’s Interview library visit: https://paragonintel.com/management-track-report-library/
- For more information on ManagementTrack’s Evasion Analysis visit: https://paragonintel.com/earnings-call-evasion/
- For more information on how ManagementTrack helps hedge funds and asset managers visit: https://paragonintel.com/
